Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 16 Oct 2026 for Corcept Therapeutics INC, €679k. Read the official filing
Filing timeline
BuySaleJames N. Wilson
Insider track record
Disclosed buys
0
Disclosed sells
17
Signal history
James N. Wilson: trading record in brief
James N. Wilson (board member) discloses dealings in Corcept Therapeutics Inc to SEC (Form 4). In total, 35 filings cover trades dated from 4 January 2015 to 15 October 2026.
No open-market purchase appears, only 17 sales worth €3.7M. The totals exclude 4 filings filed without an amount. Besides market trades, the filings include 4 option exercises. In 2026 alone, the filings show no purchases and 15 sales.
On 16 October 2026 came the latest disclosure, an open-market sale for €313k in Corcept Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James N. Wilson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
6,654 shares@ US$114.4751Common StockSEC:0001193125-26-424350:0
3,046 shares@ US$115.3895Common StockSEC:0001193125-26-424350:1
300 shares@ US$116.2967Common StockSEC:0001193125-26-424350:2
6,800 shares@ US$110.26980.0059% mcap7.6% of flowCommon StockSEC:0001193125-26-393124:0
400 shares@ US$110.83630.0003% mcap0.5% of flowCommon StockSEC:0001193125-26-393124:1
2,800 shares@ US$111.70390.0025% mcap3.2% of flowCommon StockSEC:0001193125-26-393124:2
3,053 shares@ US$110.49490.0027% mcap30.3% of flowCommon StockSEC:0001193125-26-355562:0
4,668 shares@ US$111.44250.0041% mcap46.7% of flowCommon StockSEC:0001193125-26-355562:1
2,279 shares@ US$112.63980.0020% mcap23.0% of flowCommon StockSEC:0001193125-26-355562:2
1,079 shares@ US$86.77770.0007% mcap1.0% of flowCommon StockSEC:0001193125-26-308061:0
3,969 shares@ US$87.73560.0028% mcap3.6% of flowCommon StockSEC:0001193125-26-308061:1
2,974 shares@ US$88.81050.0021% mcap2.7% of flowCommon StockSEC:0001193125-26-308061:2
1,978 shares@ US$89.48810.0014% mcap1.8% of flowCommon StockSEC:0001193125-26-308061:3
4,177 sharesCommon StockSEC:0001193125-26-275964:0
5,823 sharesCommon StockSEC:0001193125-26-275964:1
892,056 shares0Common StockSEC:0001193125-26-248953:0
9,011 shares0Common StockSEC:0001193125-26-248953:1
9,011 shares0Common StockSEC:0001193125-26-248953:2
2,000 shares0Common StockSEC:0001193125-26-177404:0
5,000 shares0Common StockSEC:0001193125-26-148488:0
4,000 shares0Common StockSEC:0001193125-26-122139:0
28,000 shares0Common StockSEC:0001193125-26-111536:0
100,000 shares@ US$3.883.9% of flowCommon StockSEC:0001193125-26-076999:0
400,000 shares0Common StockSEC:0001193125-25-321408:0
7,800 shares0Common StockSEC:0000950170-25-010499:0
25 of 35 declarations
